Related Experiment Video
Updated: May 16, 2026
03:07
Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025
Day-case robotic adrenalectomy under ERAS protocol: early outcomes from a single-centre experience
Alberto Costa Silva1,2, Aishwarya Kaur3, Safwaan Adam3
1The Christie NHS Foundation Trust, Manchester, UK. albertocsilva8@gmail.com.
World Journal of Urology
|May 14, 2026
Summary
Day-case robotic adrenalectomy within an Enhanced Recovery After Surgery (ERAS) framework is feasible and safe. This approach demonstrated excellent patient outcomes with no complications or readmissions in selected individuals.
Area of Science:
- Minimally Invasive Surgery
- Surgical Oncology
- Endocrinology
Background:
- Robotic adrenalectomy offers precision for adrenal gland procedures.
- Enhanced Recovery After Surgery (ERAS) protocols aim to optimize patient recovery and reduce hospital stays.
Purpose of the Study:
- To assess the feasibility and outcomes of implementing a day-case robotic adrenalectomy program.
- To evaluate the safety and effectiveness of integrating robotic adrenalectomy into an ERAS framework.
Main Methods:
- Retrospective analysis of patients undergoing day-case robotic adrenalectomy (Nov 2023 - Mar 2025).
- Procedures utilized the da Vinci Xi® system with an ERAS protocol including multimodal analgesia and early mobilization.
- Transversus abdominis plane (TAP) block used for intraoperative analgesia; outcomes assessed via operative metrics, complications, readmissions, and patient satisfaction (EVAN-G).
Main Results:
- Thirteen patients (median age 49, BMI 30) underwent the procedure.
- Indications included primary hyperaldosteronism, androgen-producing tumors, RCC metastasis, and adrenocortical carcinoma.
- No intraoperative or postoperative complications or 30-day readmissions were observed; median patient satisfaction score was 94/100.
Conclusions:
- Day-case robotic adrenalectomy within an ERAS protocol is a safe and well-tolerated option for selected patients.
- This approach can lead to successful outcomes with high patient satisfaction and minimal complications.
